Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Neurocrine Biosciences Inc

Neurocrine Biosciences Inc

NBIX · NASDAQ
NBIX · NASDAQ
166.40
USD-19.42-10.45%

Latest News

    @YahooFinance
    YahooFinance

    $SLNO soars on $2.9 billion Neurocrine Biosciences buyout. 📈 The deal will see Neurocrine Biosciences expand its endocrinology and rare disease portfolio. https://t.co/U7HZOux1FM

      MarketWatch

      Neurocrine Biosciences shares drop as trial failures may ‘stunt momentum,’ analysts say

        @DeItaone
        DeItaone

        Coverage Initiated $CERE $FTCH $NBIX $WTW https://t.co/HsvywOztkC https://t.co/mvopja00RD

        Analysts Recommendations

        Bullish

        Buy

        Strong Buy

        Buy

        Hold

        Sell

        Strong Sell

        Day Range

        164.38USD
        174.82USD

        52 Week Range

        122.14USD
        186.12USD

        Market Cap

        18.18BUSD

        lock-imagelock-image

        Get Full Access with Profit PRO

        See which Billionaires own this investment

        About

        General Information

        Type

        Common Stock

        Exchange

        NASDAQ

        Currency Code

        USD

        Currency Name

        US Dollar

        Country Name

        USA

        Country ISO

        US

        ISIN

        US64125C1099

        CUSIP

        64125C109

        Sector

        Healthcare

        Industry

        Drug Manufacturers - Specialty & Generic

        Fiscal Year End

        December

        IPO date

        -

        Updated At

        -

        Highlights

        PE Ratio

        27.77

        PEG Ratio

        0.51

        Book Value

        33.87

        Dividend Share

        -

        Dividend Yield

        -

        Earnings Share

        6.68

        Wall Street Target Price

        202.39

        EPS Estimate Current Year

        9.93

        EPS Estimate Next Year

        12.52

        EPS Estimate Current Quarter

        1.7305

        EPS Estimate Next Quarter

        2.0273

        Most Recent Quarter

        -

        Profitability

        Revenue TTM

        3,102,400,000

        Gross Profit TTM

        1,996,999,936

        EBITDA

        828,600,000

        Profit Margin

        21.55%

        Return On Assets TTM

        11.62%

        Return On Equity TTM

        22.50%

        Revenue Per Share TTM

        31.117

        Qtly Revenue Growth YOY

        42.20%

        Diluted Eps TTM

        6.68

        Qtly Earnings Growth YOY

        2310.50%

        Valuation

        Trailing PE

        27.77

        Forward PE

        25

        Price Sales TTM

        6.0121

        Price Book MRQ

        5.335

        Enterprise Value Revenue

        5

        Enterprise Value EBITDA

        20

        Peers analysis

        • GA
          GALDYGALDERMA GROUP AG

          45.10

          4.37%
        • Sa
          SDZNYSandoz Group AG

          84.07

          2.29%
        • MERCK Kommanditgesellschaft auf Aktien
          MKGAFMERCK Kommanditgesellschaft auf Aktien

          169.12

          1.73%
        • GD
          GDERFGDERF

          225.00

          0.65%
        • Merck KGaA ADR
          MKKGYMerck KGaA ADR

          32.96

          0.15%
        • Teva Pharmaceutical Industries Limited
          TEVJFTeva Pharmaceutical Industries Limited

          28.40

          0.00%
        • Takeda Pharmaceutical Co. Ltd.
          TKPHFTakeda Pharmaceutical Co. Ltd.

          32.53

          -6.90%
        • Haleon plc
          HLNHaleon plc

          9.87

          -2.37%
        • Teva Pharma Industries Ltd ADR
          TEVATeva Pharma Industries Ltd ADR

          34.59

          -2.27%
        • Takeda Pharmaceutical Co Ltd ADR
          TAKTakeda Pharmaceutical Co Ltd ADR

          17.14

          -0.28%
        XM

        Trade Stocks with $30 Free + Double your Deposits with a 100% Bonus

        Trade with a Trusted, Award-Winning Broker.

        Trading involves risk. The value of investments may go up or down. Trade responsibly.

        FAQs

        What is Neurocrine Biosciences stock price today?

        What is Neurocrine Biosciences stock ticker?

        Is NBIX stock price going up?

        What is the analyst recommendation for NBIX?

        What is NBIX market cap?

        Does NBIX release financial reports?

        When is NBIX next earnings date?

        What were NBIX Earnings for the last quarter?

        What was NBIX Revenue for the last quarter?

        What was NBIX Net Income for the last quarter?

        Does NBIX pay dividends?

        How many employees does NBIX have?

        What is NBIX EBITDA?

        How to buy NBIX stocks?

        Should I invest in NBIX stock?